The Advisory Committee on Immunization Practices (ACIP) has issued the 2017-2018 influenza vaccination guidelines.
Recent research suggests that perioperative and postoperative pulmonary rehabilitation improves outcomes in patients undergoing thoracic surgery.
Patients had similar outcomes with standardized treatment for community-acquired pneumococcal pneumonia regardless of HIV status.
An estimated 55% to 85% of hospital-acquired pneumonia infections involve gram-negative bacteria, while 20% to 30% of cases involve gram-positive cocci.
The rs34481144 risk allele may serve as a genetic marker for identifying individuals at increased risk for severe influenza infection.
Particulate matter exposure increased stress hormones and altered metabolic receptors.
Data from the 2015-2016 season shows that the live attenuated influenza vaccine was ineffective among children ages 2-17.
Clinical symptoms of pneumonia should be identified quickly in pediatric patients to prevent inappropriate therapy.
Influenza and pulmonary-related hospitalizations were lower in elderly patients who received the high-dose trivalent influenza vaccine vs the standard dose.
Increasing Vitamin D supplements does not prevent winter upper respiratory tract infections in young healthy children.
Influenza vaccination provided a small protective effect in patients with asthma.
Vaccinations include Fluad, Flucelvax Quadrivalent, Afluria Quadrivalent, and Fluvirin,
Pneumonia primarily affects young children, smokers, adults 65 years and older, and people with COPD.
Nearly 7000 patients with community-acquired pneumonia were examined using updated Sepsis-3 Task Force criteria.
The oral antifungal is a promising, highly potent, highly selective drug with broad-spectrum antifungal activity.
Childhood intelligence scores are associated with lower risk of mortality caused by coronary heart disease, cancers related to smoking, respiratory diseases, digestive diseases, injury, and dementia.
During the 2015-2016 flu season, approximately 59.3% of children and 41.7% of adults received the influenza vaccine.
Researchers analyzed data from hospitalized Medicare patients with acute MI, heart failure, or pneumonia between 2008 and 2014.
The 2016-2017 flu season is the first time since 2014-2015 that pediatric influenza-associated deaths have surpassed 100.
Intense exposure over the course of a single day has been linked to an elevated risk of developing chronic health conditions.
A large cohort study of critically ill patients with varicella-zoster virus-related community-acquired pneumonia found that significant morbidity and mortality are associated with the disease.
Chlorhexidine oral rinse solution 0.05% as an adjunctive intervention in daily oral hygiene care in nursing home residents does not reduce the rate of aspiration pneumonia.
One year after hospital discharge, high rates of acute respiratory distress survivors are jobless.
Right-sided abdominal pain, vomitting, fever, and mild diarrhea were all present in a 66-year-old woman with a history of sarcoidosis and hypertension.
Immunogenicity of 4 different vaccine strains, including H1N1, H3N2, and B influenza, were examined.
Between 2002 and 2012, in-hospital mortality rates for aspiration pneumonia dropped across the US.
In the week following a respiratory infection, researchers found that acute myocardial infarction risk increased sharply.
Patients with HIV who develop CAP do not need special treatment in comparison to healthy individuals according to a Barcelona study.
Videotapes of 50 visits were examined to determine whether clinician pursuit of influenza vaccine affected vaccination rates in pediatric patients.
Over 2278 health subjects were included in a multicenter study of the Seqirus IIV4 quadrivalent inactivated influenza vaccine.
Approximately 22.1% adults do not respond to initial antibiotic treatment for community-acquired pneumonia, according to new research presented at ATS 2017.
Molecular point-of-care testing for viruses led to more patients receiving single or brief doses of antibiotics without any evidence of increased harm.
A new study found no risks for exacerbation of asthma in children given LAIV, despite ACIP recommendations against its use in children with asthma.
Patients with asthma have an increased risk of pneumonia when using inhaled corticosteroids, including budesonide and fluticasone.
The American Association for Thoracic Surgery released guidelines for the management of empyema.
The inactivated monovalent influenza A(H1N1) vacccines in both adjuvanted and unadjuvanted forms were more effective in children than adults.
Despite current guidelines recommending amoxicillin in most children with community-acquired pneumonia (CAP), macrolides and broad-spectrum antibiotics continue to be prescribed for outpatient CAP.
Birth weight and week's gestation of infants at birth are not affected by maternal influenza vaccination during any trimester of pregnancy.
Intravenous zanamivir is as safe and effective as oral oseltamivir when used in patients with severe influenza.
No safety signals were observed with the administration of quadrivalent live attenuated influenza vaccine, according to a large population study.
Researchers evaluated whether administering double-dose IIV4 to children younger than 3 years of age improved protection against influenza B without increasing adverse events in a phase 3 trial.
The live attenuated influenza vaccine, LAIV, is safe in children under 2 with underlying medical conditions.
Higher-potency statins increase the risk of hospitalization for community-acquired pneumonia.
Lung ultrasounds present an effective alternative to diagnosing pneumonia.
Patients with Alzheimer's disease undergoing monotherapy with memantine have a higher risk of pneumonia.
Hospitalization rates for parapneumonic empyema in US children fell after introducing the 13 valent pneumococcal conjugate vaccine PCV13.
Switching from intravenous to oral antibiotics in patients with healthcare-associated pneumonia was found to be safe.